 | • レポートコード：20QY06-05755 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、細胞毒性薬のグローバル市場について種類別（注射剤、固形経口剤形、その他）、用途別（乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・細胞毒性薬市場の概要 ・世界の主要地域別細胞毒性薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の細胞毒性薬市場規模2015-2026：種類別（注射剤、固形経口剤形、その他） ・世界の細胞毒性薬市場規模2015-2026：用途別（乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他） ・細胞毒性薬の北米市場規模2015-2020 ・細胞毒性薬のヨーロッパ市場規模2015-2020 ・細胞毒性薬の中国市場規模2015-2020 ・細胞毒性薬の日本市場規模2015-2020 ・細胞毒性薬の東南アジア市場規模2015-2020 ・細胞毒性薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Eli Lilly、Celgene、Sanofi、eisai、Sumitomo Dainippon Pharma、Merck、Seattle Genetics、Takeda、Haosoh Pharma、Novartis、AstraZeneca、Jazz Pharma、Spectrum Pharma） ・細胞毒性薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・細胞毒性薬の市場動向・機会・課題 ・調査の結論 |
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic’ and ‘cytotoxic’ are often used interchangeably.
The classification of Cytotoxic Drug includes Injection, Solid Oral Dose Forms and others, and the proportion of Injection in 2016 is about 94%, and the proportion is in decreasing trend from 2012 to 2016.
Market Analysis and Insights: Global Cytotoxic Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cytotoxic Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cytotoxic Drug industry.
Based on our recent survey, we have several different scenarios about the Cytotoxic Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 14170 million in 2019. The market size of Cytotoxic Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Cytotoxic Drug Scope and Market Size
The global Cytotoxic Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cytotoxic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cytotoxic Drug market is segmented into
Injection
Solid Oral Dose Forms
Others
Segment by Application, the Cytotoxic Drug market is segmented into
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
The Cytotoxic Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Cytotoxic Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cytotoxic Drug Market Share Analysis
Cytotoxic Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cytotoxic Drug business, the date to enter into the Cytotoxic Drug market, Cytotoxic Drug product introduction, recent developments, etc.
The major vendors covered:
Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
AstraZeneca
Jazz Pharma
Spectrum Pharma
1 Cytotoxic Drug Market Overview
1.1 Cytotoxic Drug Product Scope
1.2 Cytotoxic Drug Segment by Type
1.2.1 Global Cytotoxic Drug Sales by Type (2020-2026)
1.2.2 Injection
1.2.3 Solid Oral Dose Forms
1.2.4 Others
1.3 Cytotoxic Drug Segment by Application
1.3.1 Global Cytotoxic Drug Sales Comparison by Application (2020-2026)
1.3.2 Breast Cancer
1.3.3 Blood Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other
1.4 Cytotoxic Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cytotoxic Drug Sales Growth Rate (2015-2026)
1.4.2 Global Cytotoxic Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Cytotoxic Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Cytotoxic Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Cytotoxic Drug Industry
1.5.1.1 Cytotoxic Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Cytotoxic Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Cytotoxic Drug Players to Combat Covid-19 Impact
2 Cytotoxic Drug Estimate and Forecast by Region
2.1 Global Cytotoxic Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cytotoxic Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cytotoxic Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Cytotoxic Drug Revenue Market Share by Region (2015-2020)
2.3 Global Cytotoxic Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cytotoxic Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cytotoxic Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cytotoxic Drug Estimates and Projections (2015-2026)
2.4.2 Europe Cytotoxic Drug Estimates and Projections (2015-2026)
2.4.3 China Cytotoxic Drug Estimates and Projections (2015-2026)
2.4.4 Japan Cytotoxic Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cytotoxic Drug Estimates and Projections (2015-2026)
2.4.6 India Cytotoxic Drug Estimates and Projections (2015-2026)
3 Global Cytotoxic Drug Competition Landscape by Players
3.1 Global Top Cytotoxic Drug Players by Sales (2015-2020)
3.2 Global Top Cytotoxic Drug Players by Revenue (2015-2020)
3.3 Global Cytotoxic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytotoxic Drug as of 2019)
3.4 Global Cytotoxic Drug Average Price by Company (2015-2020)
3.5 Manufacturers Cytotoxic Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cytotoxic Drug Players (Opinion Leaders)
4 Global Cytotoxic Drug Market Size by Type
4.1 Global Cytotoxic Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Cytotoxic Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Cytotoxic Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Cytotoxic Drug Price by Type (2014-2020)
4.2 Global Cytotoxic Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cytotoxic Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Cytotoxic Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Cytotoxic Drug Price Forecast by Type (2021-2026)
5 Global Cytotoxic Drug Market Size by Application
5.1 Global Cytotoxic Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Cytotoxic Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Cytotoxic Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Cytotoxic Drug Price by Application (2015-2020)
5.2 Global Cytotoxic Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cytotoxic Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Cytotoxic Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Cytotoxic Drug Price Forecast by Application (2021-2026)
3 North America Cytotoxic Drug Market Facts & Figures
3.2 North America Cytotoxic Drug Sales Market Share by Company (2015-2020)
3.3 North America Cytotoxic Drug Sales Market Share by Type (2015-2020)
3.4 North America Cytotoxic Drug Sales Market Share by Application (2015-2020)
4 Europe Cytotoxic Drug Market Facts & Figures
4.2 Europe Cytotoxic Drug Sales Market Share by Company (2015-2020)
4.3 Europe Cytotoxic Drug Sales Market Share by Type (2015-2020)
4.4 Europe Cytotoxic Drug Sales Market Share by Application (2015-2020)
5 China Cytotoxic Drug Market Facts & Figures
5.2 China Cytotoxic Drug Sales Market Share by Company (2015-2020)
5.3 China Cytotoxic Drug Sales Market Share by Type (2015-2020)
5.4 China Cytotoxic Drug Sales Market Share by Application (2015-2020)
6 Japan Cytotoxic Drug Market Facts & Figures
6.2 Japan Cytotoxic Drug Sales Market Share by Company (2015-2020)
6.3 Japan Cytotoxic Drug Sales Market Share by Type (2015-2020)
6.4 Japan Cytotoxic Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Cytotoxic Drug Market Facts & Figures
7.2 Southeast Asia Cytotoxic Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cytotoxic Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cytotoxic Drug Sales Market Share by Application (2015-2020)
8 India Cytotoxic Drug Market Facts & Figures
8.2 India Cytotoxic Drug Sales Market Share by Company (2015-2020)
8.3 India Cytotoxic Drug Sales Market Share by Type (2015-2020)
8.4 India Cytotoxic Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cytotoxic Drug Business
12.1 Roche
12.1.1 Roche Cytotoxic Drug Corporation Information
12.1.2 Roche Cytotoxic Drug Business Overview and Total Revenue
12.1.3 Roche Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Cytotoxic Drug Products Offered
12.1.5 Roche Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Cytotoxic Drug Corporation Information
12.2.2 Eli Lilly Cytotoxic Drug Business Overview and Total Revenue
12.2.3 Eli Lilly Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly Cytotoxic Drug Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Celgene
12.3.1 Celgene Cytotoxic Drug Corporation Information
12.3.2 Celgene Cytotoxic Drug Business Overview and Total Revenue
12.3.3 Celgene Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celgene Cytotoxic Drug Products Offered
12.3.5 Celgene Recent Development
12.4 Sanofi
12.4.1 Sanofi Cytotoxic Drug Corporation Information
12.4.2 Sanofi Cytotoxic Drug Business Overview and Total Revenue
12.4.3 Sanofi Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Cytotoxic Drug Products Offered
12.4.5 Sanofi Recent Development
12.5 eisai
12.5.1 eisai Cytotoxic Drug Corporation Information
12.5.2 eisai Cytotoxic Drug Business Overview and Total Revenue
12.5.3 eisai Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 eisai Cytotoxic Drug Products Offered
12.5.5 eisai Recent Development
12.6 Sumitomo Dainippon Pharma
12.6.1 Sumitomo Dainippon Pharma Cytotoxic Drug Corporation Information
12.6.2 Sumitomo Dainippon Pharma Cytotoxic Drug Business Overview and Total Revenue
12.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sumitomo Dainippon Pharma Cytotoxic Drug Products Offered
12.6.5 Sumitomo Dainippon Pharma Recent Development
12.7 Merck
12.7.1 Merck Cytotoxic Drug Corporation Information
12.7.2 Merck Cytotoxic Drug Business Overview and Total Revenue
12.7.3 Merck Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck Cytotoxic Drug Products Offered
12.7.5 Merck Recent Development
12.8 Seattle Genetics
12.8.1 Seattle Genetics Cytotoxic Drug Corporation Information
12.8.2 Seattle Genetics Cytotoxic Drug Business Overview and Total Revenue
12.8.3 Seattle Genetics Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Seattle Genetics Cytotoxic Drug Products Offered
12.8.5 Seattle Genetics Recent Development
12.9 Takeda
12.9.1 Takeda Cytotoxic Drug Corporation Information
12.9.2 Takeda Cytotoxic Drug Business Overview and Total Revenue
12.9.3 Takeda Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Takeda Cytotoxic Drug Products Offered
12.9.5 Takeda Recent Development
12.10 Haosoh Pharma
12.10.1 Haosoh Pharma Cytotoxic Drug Corporation Information
12.10.2 Haosoh Pharma Cytotoxic Drug Business Overview and Total Revenue
12.10.3 Haosoh Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Haosoh Pharma Cytotoxic Drug Products Offered
12.10.5 Haosoh Pharma Recent Development
12.11 Novartis
12.11.1 Novartis Cytotoxic Drug Corporation Information
12.11.2 Novartis Cytotoxic Drug Business Overview and Total Revenue
12.11.3 Novartis Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Cytotoxic Drug Products Offered
12.11.5 Novartis Recent Development
12.12 AstraZeneca
12.12.1 AstraZeneca Cytotoxic Drug Corporation Information
12.12.2 AstraZeneca Cytotoxic Drug Business Overview and Total Revenue
12.12.3 AstraZeneca Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 AstraZeneca Cytotoxic Drug Products Offered
12.12.5 AstraZeneca Recent Development
12.13 Jazz Pharma
12.13.1 Jazz Pharma Cytotoxic Drug Corporation Information
12.13.2 Jazz Pharma Cytotoxic Drug Business Overview and Total Revenue
12.13.3 Jazz Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Jazz Pharma Cytotoxic Drug Products Offered
12.13.5 Jazz Pharma Recent Development
12.14 Spectrum Pharma
12.14.1 Spectrum Pharma Cytotoxic Drug Corporation Information
12.14.2 Spectrum Pharma Cytotoxic Drug Business Overview and Total Revenue
12.14.3 Spectrum Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Spectrum Pharma Cytotoxic Drug Products Offered
12.14.5 Spectrum Pharma Recent Development
13 Cytotoxic Drug Manufacturing Cost Analysis
13.1 Cytotoxic Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cytotoxic Drug
13.4 Cytotoxic Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cytotoxic Drug Distributors List
14.3 Cytotoxic Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cytotoxic Drug Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Cytotoxic Drug Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Cytotoxic Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Cytotoxic Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Cytotoxic Drug Players to Combat Covid-19 Impact
Table 8. Global Market Cytotoxic Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Cytotoxic Drug Sales (K Units) by Region (2015-2020)
Table 10. Global Cytotoxic Drug Sales Market Share by Region (2015-2020)
Table 11. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Cytotoxic Drug Revenue Share by Region (2015-2020)
Table 13. Global Cytotoxic Drug Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Cytotoxic Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Cytotoxic Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Cytotoxic Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Cytotoxic Drug (K Units) of Key Companies (2015-2020)
Table 18. Global Cytotoxic Drug Sales Share by Company (2015-2020)
Table 19. Global Cytotoxic Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Cytotoxic Drug Revenue Share by Company (2015-2020)
Table 21. Global Cytotoxic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytotoxic Drug as of 2019)
Table 22. Global Cytotoxic Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Cytotoxic Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Cytotoxic Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Cytotoxic Drug Players
Table 27. Global Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 28. Global Cytotoxic Drug Sales Share by Type (2015-2020)
Table 29. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Cytotoxic Drug Price (K Units) by Type (2015-2020)
Table 31. Global Cytotoxic Drug Sales Share by Type (2021-2026)
Table 32. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Cytotoxic Drug Revenue Share by Type (2021-2026)
Table 34. Global Cytotoxic Drug Price (K Units) by Type (2021-2026)
Table 35. Global Cytotoxic Drug Sales (K Units) by Application (2015-2020)
Table 36. Global Cytotoxic Drug Sales Share by Application (2015-2020)
Table 37. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Cytotoxic Drug Price (K Units) by Application (2015-2020)
Table 39. Global Cytotoxic Drug Sales (K Units) by Application (2021-2026)
Table 40. Global Cytotoxic Drug Sales Share by Application (2021-2026)
Table 41. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Cytotoxic Drug Revenue Share by Application (2021-2026)
Table 43. Global Cytotoxic Drug Price (K Units) by Application (2021-2026)
Table 44. United States Cytotoxic Drug Sales (K Units) by Company (2015-2020)
Table 45. United States Cytotoxic Drug Sales Market Share by Company (2015-2020)
Table 46. United States Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 47. United States Cytotoxic Drug Sales Market Share by Type (2015-2020)
Table 48. United States Cytotoxic Drug Sales (K Units) by Application (2015-2020)
Table 49. United States Cytotoxic Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Cytotoxic Drug Sales (K Units) by Company (2015-2020)
Table 51. Europe Cytotoxic Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 53. Europe Cytotoxic Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Cytotoxic Drug Sales (K Units) by Application (2015-2020)
Table 55. Europe Cytotoxic Drug Sales Market Share by Type (2015-2020)
Table 56. China Cytotoxic Drug Sales (K Units) by Company (2015-2020)
Table 57. China Cytotoxic Drug Sales Market Share by Company (2015-2020)
Table 58. China Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 59. China Cytotoxic Drug Sales Market Share by Type (2015-2020)
Table 60. China Cytotoxic Drug Sales (K Units) by Application (2015-2020)
Table 61. China Cytotoxic Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Cytotoxic Drug Sales (K Units) by Company (2015-2020)
Table 63. Japan Cytotoxic Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 65. Japan Cytotoxic Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Cytotoxic Drug Sales (K Units) by Application (2015-2020)
Table 67. Japan Cytotoxic Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Cytotoxic Drug Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Cytotoxic Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Cytotoxic Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Cytotoxic Drug Sales Market Share by Application (2015-2020)
Table 74. India Cytotoxic Drug Sales (K Units) by Company (2015-2020)
Table 75. India Cytotoxic Drug Sales Market Share by Company (2015-2020)
Table 76. India Cytotoxic Drug Sales (K Units) by Type (2015-2020)
Table 77. India Cytotoxic Drug Sales Market Share by Type (2015-2020)
Table 78. India Cytotoxic Drug Sales (K Units) by Application (2015-2020)
Table 79. India Cytotoxic Drug Sales Market Share by Application (2015-2020)
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Roche Cytotoxic Drug Product
Table 84. Roche Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eli Lilly Cytotoxic Drug Product
Table 89. Eli Lilly Recent Development
Table 90. Celgene Corporation Information
Table 91. Celgene Description and Business Overview
Table 92. Celgene Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Celgene Cytotoxic Drug Product
Table 94. Celgene Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sanofi Cytotoxic Drug Product
Table 99. Sanofi Recent Development
Table 100. eisai Corporation Information
Table 101. eisai Description and Business Overview
Table 102. eisai Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. eisai Cytotoxic Drug Product
Table 104. eisai Recent Development
Table 105. Sumitomo Dainippon Pharma Corporation Information
Table 106. Sumitomo Dainippon Pharma Description and Business Overview
Table 107. Sumitomo Dainippon Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sumitomo Dainippon Pharma Cytotoxic Drug Product
Table 109. Sumitomo Dainippon Pharma Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Merck Cytotoxic Drug Product
Table 114. Merck Recent Development
Table 115. Seattle Genetics Corporation Information
Table 116. Seattle Genetics Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Seattle Genetics Description and Business Overview
Table 118. Seattle Genetics Cytotoxic Drug Product
Table 119. Seattle Genetics Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Takeda Description and Business Overview
Table 123. Takeda Cytotoxic Drug Product
Table 124. Takeda Recent Development
Table 125. Haosoh Pharma Corporation Information
Table 126. Haosoh Pharma Description and Business Overview
Table 127. Haosoh Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Haosoh Pharma Cytotoxic Drug Product
Table 129. Haosoh Pharma Recent Development
Table 130. Novartis Corporation Information
Table 131. Novartis Description and Business Overview
Table 132. Novartis Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Novartis Cytotoxic Drug Product
Table 134. Novartis Recent Development
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. AstraZeneca Cytotoxic Drug Product
Table 139. AstraZeneca Recent Development
Table 140. Jazz Pharma Corporation Information
Table 141. Jazz Pharma Description and Business Overview
Table 142. Jazz Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Jazz Pharma Cytotoxic Drug Product
Table 144. Jazz Pharma Recent Development
Table . Spectrum Pharma Corporation Information
Table . Spectrum Pharma Description and Business Overview
Table . Spectrum Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Spectrum Pharma Cytotoxic Drug Product
Table . Spectrum Pharma Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Cytotoxic Drug Distributors List
Table 153. Cytotoxic Drug Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Cytotoxic Drug Product Picture
Figure 2. Global Cytotoxic Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cytotoxic Drug Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer Examples
Figure 7. Blood Cancer Examples
Figure 8. Prostate Cancer Examples
Figure 9. Respiratory/Lung Cancer Examples
Figure 10. Other Examples
Figure 11. Global Cytotoxic Drug Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Cytotoxic Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Cytotoxic Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Cytotoxic Drug Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Cytotoxic Drug Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Cytotoxic Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Cytotoxic Drug Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Cytotoxic Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Cytotoxic Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Cytotoxic Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Cytotoxic Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Cytotoxic Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Cytotoxic Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Cytotoxic Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Cytotoxic Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Cytotoxic Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Cytotoxic Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Cytotoxic Drug Players Market Share by Revenue in Cytotoxic Drug 2015 & 2019
Figure 29. Cytotoxic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Cytotoxic Drug Revenue Share by Type (2015-2020)
Figure 31. Global Cytotoxic Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Cytotoxic Drug Revenue Share by Application (2015-2020)
Figure 33. Global Cytotoxic Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Cytotoxic Drug Sales Market Share by Type in 2019
Figure 35. United States Cytotoxic Drug Sales Market Share by Type in 2019
Figure 36. Europe Cytotoxic Drug Sales Market Share by Company in 2019
Figure 37. Europe Cytotoxic Drug Sales Market Share by Type in 2019
Figure 38. Europe Cytotoxic Drug Sales Market Share by Application in 2019
Figure 39. China Cytotoxic Drug Sales Market Share by Company in 2019
Figure 40. China Cytotoxic Drug Sales Market Share by Type in 2019
Figure 41. China Cytotoxic Drug Sales Market Share by Application in 2019
Figure 42. Japan Cytotoxic Drug Sales Market Share by Company in 2019
Figure 43. Japan Cytotoxic Drug Sales Market Share by Type in 2019
Figure 44. Japan Cytotoxic Drug Sales Market Share by Application in 2019
Figure 45. Southeast Asia Cytotoxic Drug Sales Market Share by Company in 2019
Figure 46. Southeast Asia Cytotoxic Drug Sales Market Share by Type in 2019
Figure 47. Southeast Asia Cytotoxic Drug Sales Market Share by Application in 2019
Figure 48. India Cytotoxic Drug Sales Market Share by Company in 2019
Figure 49. India Cytotoxic Drug Sales Market Share by Type in 2019
Figure 50. India Cytotoxic Drug Sales Market Share by Application in 2019
Figure 51. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sumitomo Dainippon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Haosoh Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Jazz Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Spectrum Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of Cytotoxic Drug
Figure 67. Manufacturing Process Analysis of Cytotoxic Drug
Figure 68. Cytotoxic Drug Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
濾胞甲状腺がん治療薬の世界市場レポート2020 Market Analysis and Insights: Global Follicular Thyroid Cancer Drug Market The global Follicular Thyroid Cancer Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Follicular Thyroid Cancer Drug Scope an…- 上咽頭癌治療薬の世界市場レポート2020 Market Analysis and Insights: Global Nasopharyngeal Cancer Drug Market The global Nasopharyngeal Cancer Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nasopharyngeal Cancer Drug Scope and Market Siz…
- 癌抗体薬物コンジュゲートの世界市場レポート2020 Market Analysis and Insights: Global Cancer Antibody Drug Conjugates Market The global Cancer Antibody Drug Conjugates market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cancer Antibody Drug Conjugates Scope…
- 小分子がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Small Molecule Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Small Molecule Can…
- 抗体薬物複合体の世界市場レポート2020 Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…